SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193805-05-002142
Filing Date
2005-10-25
Accepted
2005-10-25 14:00:16
Documents
1
Group Members
LARRY CHACHKESMICHAEL CHOTHOMAS TURALSKI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G e501084_sc13g-biocryst.txt SC 13G 21889
  Complete submission text file 0001193805-05-002142.txt   23758
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44055 | Film No.: 051154041
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FIRST NEW YORK SECURITIES, LLC 850 THIRD AVENUE, 8TH FLOOR NEW YORK NY 10022
Business Address
EDELMAN JOSEPH (Filed by) CIK: 0001164426 (see all company filings)

Type: SC 13G